Sonnet BioTherapeutics Holdings, Inc (SONN) insider trading

Every open-market stock purchase and sale by Sonnet BioTherapeutics Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Pankaj Mohan (CEO), $110K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent SONN insider trades

DateInsiderTradeValue
Dec 2, 2025Richard T Kenney (C-suite exec)Sold (not open market)$400K
Dec 2, 2025Richard T Kenney (C-suite exec)Bought (not open market)$100K
Dec 2, 2025Richard T Kenney (C-suite exec)Bought (not open market)$250
Dec 2, 2025Richard T Kenney (C-suite exec)Sold (not open market)—
Dec 2, 2025Donald J. Griffith (CFO)Sold (not open market)—
Dec 2, 2025Richard T Kenney (C-suite exec)Sold (not open market)—
Dec 2, 2025Raghu Rao (CEO)Sold (not open market)—
Dec 2, 2025Richard T Kenney (C-suite exec)Bought (not open market)—
Dec 2, 2025Richard T Kenney (C-suite exec)Sold (not open market)—
Dec 2, 2025Stephen J McAndrew (C-suite exec)Sold (not open market)—
Dec 2, 2025Susan Dexter (Director)Sold (not open market)—
Dec 2, 2025Nailesh Bhatt (Director)Sold (not open market)—
Dec 2, 2025John K. Cini (Director)Sold (not open market)—
Dec 2, 2025Lori McNeill (Director)Sold (not open market)—
Dec 2, 2025Albert D. Dyrness (Director)Sold (not open market)—
Dec 2, 2025Richard T Kenney (C-suite exec)Sold (not open market)—

Who's trading SONN

Get free alerts when an insider at Sonnet BioTherapeutics Holdings, Inc files a new trade →